Charles River Laboratories reinforced its commitment to strengthening the Asia Pacific biomanufacturing ecosystem by sig...
As global demand for biologics, advanced therapies, and complex biopharmaceuticals continues to expand, the conversation...
In the session titled Strategic Foundations Regulatory Innovation And Global Outlook, Sam Chuang, Execut...
Opening the keynote session of the APAC Biomanufacturing Leadership Summit 2026, Pengfei Chen highlighted the rapid tran...
Although the peptide is not widely discussed in mainstream literature, its conceptual foundations align with broader inv...
Hangzhou Sciwind Biosciences has announced that China's National Medical Products Administration (NMPA) has approved Ecn...
Germany-based Grünenthal, a global leader in pain management and related diseases, and South Korea's BCWorld Pharm ...
As global life sciences companies seek locations that combine skilled talent, scalable infrastructure, a...
Taiwan-based Senhwa Biosciences, Inc. has announced the signing of a major strategic Memorandum of Understanding (MoU) w...
International Dental Exhibition & Meeting 2026 (IDEM 2026), Asia-Pacific’s leading dental exhibition and confe...
Diabetes prevalence in the Asia-Pacific region is rising rapidly, bringing increased focus on scaling treatments such ...
Cirrus Therapeutics announced several business and pipeline updates to support its growth as a leading global ocular imm...
The World Health Expo (WHX) launched the first edition of WHX Leaders in Dubai , an invitation-only leadership platform ...
Aicuris Anti-infective Cures AG has entered into a definitive agreement under which Japan's Asahi Kasei, through it...
As pharmaceutical companies strive to remain competitive in the market, optimizing operations, productivity, efficiency,...
US-based Sarepta Therapeutics, Inc. has announced the commercial launch of ELEVIDYS (delandistrogene moxeparvovec) in Ja...
CPHI Middle East and BIO Middle East are set to position Saudi Arabia at the forefront of the global life sciences secto...
Hangzhou Sciwind Biosciences has announced a strategic commercialisation collaboration with Pfizer China for Ecnoglutide...
Taiwan-based Formosa Pharmaceuticals has entered into an exclusive licensing agreement with Arrotex Pharmaceuticals...
ImmunityBio, Inc., a commercial-stage immunotherapy company based in the US, has announced a partnership with Biopharma ...
The Ministry of Health and Welfare (MoHW), South Korea government, and the Korea Health Industry Development Institute (...
US-based BostonGene, the developer of the leading AI foundation model for tumour and immune biology, has announced ...
Clinigen, a global leader in accelerating patient access to critical medicines, obtained the world's first prescription ...
Japan-headquartered Nxera Pharma has entered into a license agreement with a newly established independent company (NewC...
Singapore-based iX Biopharma has been awarded a $40.95 million development contract by the United States Government to f...
